Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,101 total articles
Amir F Heshmatpour, president of NeonC Technologies Holdings, Inc. (NASDAQ:NTHI), purchased 25,000 shares of the company's common stock in two transactions totaling $153,398, according to a Form 4 filing. The purchases occurred on April 2 and April 6, 2026, while the stock traded below recent highs. Separately, the company disclosed a private place…
Daniel J. Lippis, CVP of TAVR at Edwards Lifesciences (NYSE:EW), sold 1,019 shares on April 6, 2026 for $82,522 and exercised options to acquire the same number of shares at $59.2567 per share. The transactions were made under a Rule 10b5-1 trading plan adopted July 30, 2025. Edwards reported mixed fourth-quarter results and announced positive two-…
Penumbra Inc. director Grewal Harpreet sold 100 shares on April 2, 2026, for $32,822 under a Rule 10b5-1 plan. The transaction follows a 32% rally over six months and comes as the company reported stronger-than-expected fourth-quarter 2025 results and announced a proposed acquisition by Boston Scientific valued at $374 per share.
Gagan Jain, Vice President of Worldwide Sales at Power Integrations Inc. (POWI), reported a sale of 313 shares on April 2, 2026, executed to satisfy tax obligations tied to a vested Restricted Stock Award. The trade, disclosed in a Form 4 filing with the SEC, amounted to $16,253. The stock has risen roughly 45% year-to-date and sits near $51.44 wit…
Director Higuchi John W. bought 123,000 shares of Lipocine Inc. (NASDAQ: LPCN) on April 6, 2026, for $2.05 per share, a transaction totaling $252,149. The purchase brings his direct holdings to 163,797 shares. The transaction coincides with the stock trading close to a 52-week low, and follows Phase 3 trial results for LPCN 1154 that missed the pri…
John W. Schlosser, Vice President and President, Terminals at Kinder Morgan, sold 6,166 shares of Class P common stock on April 6, 2026, for roughly $203,071 under a pre-established 10b5-1 plan. The disposal occurred while KMI shares trade near a 52-week high and amid a patchwork of recent analyst revisions and corporate pipeline developments.
RA Capital Management and affiliated parties sold a combined 842,282 shares of Vor Biopharma Inc. (NASDAQ: VOR) in multiple transactions on April 2 and April 6, 2026, generating proceeds of about $14.5 million. The disposals took place as VOR's share price traded with notable volatility and followed a period of fresh financing and clinical mileston…
Magnetar Financial LLC, a roughly 10% holder of Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR), sold a total of 23,088 shares of Wheeler common stock between April 1 and April 6, 2026, for approximately $21,460. The trades came in three blocks at weighted average prices from $0.9234 to $0.9466 per share. Wheeler continues to adjust its c…
Lipocine Inc. (NASDAQ:LPCN) Chief Executive Officer Mahesh V. Patel purchased 25,000 shares of company stock on April 6, 2026 at $2.03 per share, totaling $50,749. The transaction occurs as the share price trades close to a 52-week low of $1.81 after a 74% decline over the prior week. Separately, Lipocine disclosed that its postpartum depression dr…
Arve Hanstveit, a director at Energy Recovery, Inc. (NASDAQ: ERII), sold 165,292 shares on April 2, 2026, for roughly $1.67 million at $10.14 per share. The disposition was executed by a broker without Hanstveit's instruction to satisfy a margin call on shares pledged as collateral. The transaction comes as Energy Recovery reported fourth-quarter 2…
Paul L. Alpern, Vice President and General Counsel of Arteris, Inc. (NASDAQ: AIP), sold 3,649 shares of common stock on April 2, 2026, in transactions executed at $17.6528 per share, totaling $64,415. The disposals were carried out to satisfy tax obligations tied to the release of restricted stock units and were not described as discretionary trade…
Planet Labs PBC President and CFO Ashley F. Johnson sold 200,000 Class A shares on April 2, 2026, for roughly $7,020,218, and on April 6, 2026 moved 525,708 shares into The Johnson Joint Revocable Trust. The company also reported stronger-than-expected fourth-quarter fiscal 2026 results, received mixed analyst target revisions, announced a Pelican …
Lightwave Logic director Thomas M. Connelly Jr. sold 9,000 shares of common stock on April 6, 2026, for $8.52 per share, yielding $76,680. The sale, disclosed on a Form 4, was made to meet tax-withholding obligations tied to restricted stock unit vestings on March 31, 2026. The move comes as Lightwave Logic's stock has climbed 786% over the past ye…
Charles Janac, president and chief executive of Arteris, Inc. (NASDAQ:AIP), sold a combined $375,438 of company stock in two transactions on April 2 and April 6. The April 2 sales covered tax obligations from restricted stock units, while the April 6 sale occurred under a 10b5-1 plan adopted March 5, 2025. The moves coincide with a steep share-pric…
Arteris, Inc. CFO Nicholas B. Hawkins disposed of 5,870 shares on April 2, 2026, in multiple transactions disclosed on a Form 4, raising $85,969. The sales were reported as tax-covering actions tied to the vesting of restricted stock units. Arteris recently posted better-than-expected fourth-quarter 2025 results, while InvestingPro flags the stock …
Arteris, Inc. (NASDAQ: AIP) Chief Operating Officer Laurent R. Moll sold a combined $127,182 of company shares on April 2 and April 6, with the April 2 transactions intended to cover tax liabilities tied to restricted stock units and the April 6 sale conducted under a prearranged 10b5-1 plan. The moves come as Arteris shares trade near a 52-week hi…
Iridium Communications Inc. (NASDAQ: IRDM) reported two insider sales by Timothy Kapalka, Chief Administrative Officer of Iridium Satellite LLC, totaling 5,833 shares and $184,909 in proceeds. The sales occurred on April 2 and April 6 at $31.00 and $33.00 per share, respectively. The disclosures arrive while IRDM trades near its 52-week high follow…
Beam Therapeutics Chief Medical Officer Amy Simon sold 6,700 shares on April 1, 2026, in an automated transaction to satisfy tax withholding tied to vesting restricted stock units. The sale, executed under a Rule 10b5-1 trading plan adopted May 19, 2023, totaled $164,686. Beam shares trade near $24.23 amid recent clinical data releases that have le…
Altimmune director John Gill purchased 9,200 shares of company stock on April 6, 2026, paying between $3.4050 and $3.4080 per share for a total of $31,349. The transaction occurred while the shares have climbed more than 15% in the prior week. The company recently posted fourth-quarter 2025 results that missed expectations on both EPS and revenue, …
Beam Therapeutics Inc. CEO John M. Evans sold 30,078 shares on April 1, 2026, generating about $739,317 to satisfy tax-withholding tied to the vesting of restricted stock units. The sale, executed under a Rule 10b5-1 plan adopted in May 2023, leaves Evans with direct and indirect holdings exceeding 1.15 million shares. Separately, Beam published Ph…
Lands’ End CFO and Treasurer Bernard Louis McCracken III sold 3,362 shares of common stock on April 1, 2026, at $45 per share, totaling $151,290, while exercising and receiving additional shares at no cost. The transactions occurred as the stock trades well below that sale price and after the company reported a fourth-quarter earnings and revenue m…
UWM Holdings Corp saw combined insider sales of 2,001,148 Class A shares by CEO Mat Ishbia and 10%-owner SFS Holding Corp for about $7.4 million across two transactions in early April 2026. The trades coincide with volatile share performance, dividend yield above 10%, recent quarterly revenue beats and ongoing merger-related developments involving …
DoorDash director Stanley Tang sold 23,125 shares of Class A stock on April 2, 2026, for $150 per share, totaling $3,468,750. The sale, carried out under a Rule 10b5-1 plan established December 3, 2025, leaves Tang with a mix of direct and indirect holdings across Class A and Class B shares. The company also announced a national delivery partnershi…
Entities tied to GEC Partners III LP sold a combined $24,774,750 of Flowco Holdings Inc. (NASDAQ: FLOC) Class A common stock on March 26, 2026, at $21.175 per share, while simultaneously acquiring equivalent amounts through conversion of LLC interests. The stock trades at $20.69 with a $1.86 billion market capitalization, and InvestingPro's Fair Va…
Bethany Cavanagh, Beam Therapeutics' SVP of Finance and Treasurer, sold 3,242 shares on April 1, 2026, under a Rule 10b5-1 plan to meet tax withholding obligations tied to RSU vesting. The transaction totaled $79,688. Beam has recently disclosed clinical data from its BEACON sickle cell program and BEAM-302 alpha-1 antitrypsin deficiency study, pro…
